Stay updated on Elranatamab Combo Therapy in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Elranatamab Combo Therapy in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Elranatamab Combo Therapy in Multiple Myeloma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.5.4 is displayed instead of v3.5.3 on the page, indicating a minor system update to the Study History page.
    Difference
    0.1%
    Check dated 2026-05-21T13:46:17.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Pfizer terminated the MagnetisMM-4 umbrella study and will not pursue the Phase 2 expansion, changing its status to Terminated; the termination note specifies it was not due to safety concerns or regulatory requests.
    Difference
    0.5%
    Check dated 2026-04-30T03:25:03.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The page revision label changes from v3.5.0 to v3.5.2, with no other study record content updates shown.
    Difference
    0.1%
    Check dated 2026-04-22T18:14:56.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    A new revision entry v3.5.0 was added to the history. An earlier revision v3.4.3 was removed from the list.
    Difference
    0.1%
    Check dated 2026-03-25T01:22:27.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    New revision entry v3.4.3 added to the history. Old revision v3.4.2 removed.
    Difference
    0.1%
    Check dated 2026-03-10T14:40:50.000Z thumbnail image
  9. Check
    100 days ago
    Change Detected
    Summary
    Result-related sections were added to the record, including Results Posted, Adverse Events, Baseline Characteristics, Participant Flow, and Outcome Measures, consolidating detailed trial data. The previous entry 'Results Submitted' was removed.
    Difference
    0.9%
    Check dated 2026-02-24T09:16:59.000Z thumbnail image

Stay in the know with updates to Elranatamab Combo Therapy in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Elranatamab Combo Therapy in Multiple Myeloma Clinical Trial page.